| 000 | 01353 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512023423.0 | ||
| 264 | 0 | _c19870410 | |
| 008 | 198704s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(87)90250-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVague, P | |
| 245 | 0 | 0 |
_aNicotinamide may extend remission phase in insulin-dependent diabetes. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 1987 |
||
| 300 |
_a619-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aVialettes, B | |
| 700 | 1 | _aLassmann-Vague, V | |
| 700 | 1 | _aVallo, J J | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8533 _gp. 619-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(87)90250-9 _zAvailable from publisher's website |
| 999 |
_c2886992 _d2886992 |
||